niche industry
information & intelligence
on drug delivery logo

June 2010:
INJECTABLE DRUG DELIVERY 2010: FORMULATIONS FOCUS

DOWNLOAD COMPLETE ISSUE PDF

CONTENTS:

Introduction
Protein Pharmaceuticals: Recent Achievements and Trends for Formulation and Delivery

Henrik L. Luessen, Tytonis BV, and Gerrit Borchard, University of Geneva

ARTICLE PDF

Lipid Liquid Crystals for Parenteral Sustained-Release Applications: Combining Ease of Use and Manufacturing with Consistent Drug Release Control
Fredrik Tiberg, PhD, Prof, President & CEO, and Fredrik Joabsson, PhD, Director, Drug Delivery Systems and Technical Business Development
Camurus AB

ARTICLE PDF

Company profile
Nanomi BV

PROFILE PDF

Intrathecal Delivery of Protein Therapeutics to Treat Genetic Diseases Involving the CNS
Zahra Shahrokh, PhD, Senior Director, Pharmaceutical and Analytical Development, Perry Calias, PhD, Senior Director, Nonclinical Development, and Lawrence Charnas, MD, PhD, Medical Director
Shire Human Genetic Therapies, Inc

ARTICLE PDF

Dendrimers Enhance Delivery of Small-Molecule and Biological Drugs: Control Solubility, Half-Life, Toxicity and Targeting
David Owen, PhD, VP Research, and Paul Barrett, PhD, VP Business Development
Starpharma Holdings Limited

ARTICLE PDF

Contrasol™: Novel Nanotechnology for the Enhanced Development of Intravenous Formulations
Alison Foster, PhD, Laboratory Director
IOTA NanoSolutions, Ltd

ARTICLE PDF

DOWNLOAD COMPLETE ISSUE PDF

Download the Current Issue

PDA


 click through to website